Zejula 100 mg hard capsules, Zejula 100 mg film-coated tablets, JEMPERLI 500 mg concentrate for solution for infusion
GINECO-EN203b
Phase 2 small_molecule active
Quick answer
Zejula 100 mg hard capsules, Zejula 100 mg film-coated tablets, JEMPERLI 500 mg concentrate for solution for infusion for metastatic or recurrent endometrial or ovarian carcinosarcoma is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- metastatic or recurrent endometrial or ovarian carcinosarcoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active